[What can the clinician expect today from PSA determination?].

Since its characterization in 1979, PSA has become an indispensable tumoral marker to justify hospitalization of patients with prostate cancer. In addition to being a standard tumor marker used to follow the course of the disease, PSA can also be used as a therapeutic indicator of prostate cancer. PSA is becoming increasingly important for this latter application.